Title: 3 HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES
Official Title: 3 HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES
Number of Sections: 1
Source: versions - Adopted Amendments
Media Type: application/pdf
Strikethrough Detection: 2 sections found

================================================================================

Section 1:
1 L.D. 178
2 Date: (Filing No. H- )
4 Reproduced and distributed under the direction of the Clerk of the House.
5 STATE OF MAINE
6 HOUSE OF REPRESENTATIVES
7 132ND LEGISLATURE
8 FIRST SPECIAL SESSION
9 COMMITTEE AMENDMENT “ ” to H.P. 111, L.D. 178, “An Act Regarding
10 Coverage for Step Therapy for Advanced Metastatic Cancer”
11 Amend the bill by striking out the title and substituting the following:
12 'An Act Regarding Coverage for Step Therapy for Metastatic Cancer'
13 Amend the bill by striking out everything after the enacting clause and inserting the
14 following:
15 'Sec. 1. 24-A MRSA §4320-N, sub-§1, ¶A-1 is enacted to read:
16 A-1. "Associated conditions" means the symptoms or side effects associated with
17 metastatic cancer or its treatment and that, in the judgment of the health care
18 practitioner, further jeopardize the health of a patient if left untreated.
19 Sec. 2. 24-A MRSA §4320-N, sub-§1, ¶C-1 is enacted to read:
20 C-1. "Metastatic cancer" means cancer that has spread from the primary or original
21 site of the cancer to nearby tissues, lymph nodes or other areas or parts of the body.
22 Sec. 3. 24-A MRSA §4320-N, sub-§8 is enacted to read:
23 8. Step therapy for metastatic cancer and associated conditions prohibited.
24 Notwithstanding subsection 6, paragraph B, with respect to coverage of a prescription drug
25 on a carrier's formulary for the treatment of metastatic cancer and associated conditions, a
26 carrier or utilization review organization may not require that the enrollee use a step therapy
27 protocol before the carrier provides coverage of a prescription drug approved by the United
28 States Food and Drug Administration.
29 Sec. 4. Appropriations and allocations. The following appropriations and
30 allocations are made.
31 ADMINISTRATIVE AND FINANCIAL SERVICES, DEPARTMENT OF
32 Departments and Agencies - Statewide 0016
Page 1 - 132LR0578(02)
COMMITTEE AMENDMENT
COMMITTEE AMENDMENT “ ” to H.P. 111, L.D. 178
1 Initiative: Provides funding to allow enrollees to use step therapy protocols before the
2 carrier provides coverage of prescription drugs approved by the United States Food and
3 Drug Administration. The expanded requirements apply to health plans issued or renewed
4 on or after January 1, 2026.
5 GENERAL FUND 2025-26 2026-27
6 All Other $0 $7,176
7 __________ __________
8 GENERAL FUND TOTAL $0 $7,176
95
10 HIGHWAY FUND 2025-26 2026-27
11 All Other $0 $2,496
12 __________ __________
13 HIGHWAY FUND TOTAL $0 $2,496
1140 '
15 Amend the bill by relettering or renumbering any nonconsecutive Part letter or section
16 number to read consecutively.
17 SUMMARY
1188 This amendment replaces the bill and changes the title. With respect to coverage of a
1199 prescription drug on a carrier's formulary for the treatment of metastatic cancer and
2200 associated conditions, the amendment prohibits a health insurance carrier or utilization
2211 review organization from requiring an enrollee to use a step therapy protocol before the
2222 carrier provides coverage of a prescription drug approved by the United States Food and
2233 Drug Administration. The amendment also adds an appropriations and allocations section.
2244 FISCAL NOTE REQUIRED
2255 (See attached)
Page 2 - 132LR0578(02)
COMMITTEE AMENDMENT
[DELETED: LD:(RC A “ t H 1 L 1 “ A R0C1A2'3A4f5' 6A7m c o i t a t i t j o t h c8p9 0C1s2 38  S t f m c a a c p4N5o6c7p8S9  T f a a 4  A a a0a1A2D]
[DELETED: IcDoD262r$0$___L$0$D262r$0$___L$0$05A6n8T9p d o a c f f t t o m c a0a1r2c3D4F5(]


================================================================================

Raw Text:
1 L.D. 178
2 Date: (Filing No. H- )
3 HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES
4 Reproduced and distributed under the direction of the Clerk of the House.
5 STATE OF MAINE
6 HOUSE OF REPRESENTATIVES
7 132ND LEGISLATURE
8 FIRST SPECIAL SESSION
9 COMMITTEE AMENDMENT “ ” to H.P. 111, L.D. 178, “An Act Regarding
10 Coverage for Step Therapy for Advanced Metastatic Cancer”
11 Amend the bill by striking out the title and substituting the following:
12 'An Act Regarding Coverage for Step Therapy for Metastatic Cancer'
13 Amend the bill by striking out everything after the enacting clause and inserting the
14 following:
15 'Sec. 1. 24-A MRSA §4320-N, sub-§1, ¶A-1 is enacted to read:
16 A-1. "Associated conditions" means the symptoms or side effects associated with
17 metastatic cancer or its treatment and that, in the judgment of the health care
18 practitioner, further jeopardize the health of a patient if left untreated.
19 Sec. 2. 24-A MRSA §4320-N, sub-§1, ¶C-1 is enacted to read:
20 C-1. "Metastatic cancer" means cancer that has spread from the primary or original
21 site of the cancer to nearby tissues, lymph nodes or other areas or parts of the body.
22 Sec. 3. 24-A MRSA §4320-N, sub-§8 is enacted to read:
23 8. Step therapy for metastatic cancer and associated conditions prohibited.
24 Notwithstanding subsection 6, paragraph B, with respect to coverage of a prescription drug
25 on a carrier's formulary for the treatment of metastatic cancer and associated conditions, a
26 carrier or utilization review organization may not require that the enrollee use a step therapy
27 protocol before the carrier provides coverage of a prescription drug approved by the United
28 States Food and Drug Administration.
29 Sec. 4. Appropriations and allocations. The following appropriations and
30 allocations are made.
31 ADMINISTRATIVE AND FINANCIAL SERVICES, DEPARTMENT OF
32 Departments and Agencies - Statewide 0016
Page 1 - 132LR0578(02)
COMMITTEE AMENDMENT

COMMITTEE AMENDMENT “ ” to H.P. 111, L.D. 178
1 Initiative: Provides funding to allow enrollees to use step therapy protocols before the
2 carrier provides coverage of prescription drugs approved by the United States Food and
3 Drug Administration. The expanded requirements apply to health plans issued or renewed
4 on or after January 1, 2026.
5 GENERAL FUND 2025-26 2026-27
6 All Other $0 $7,176
7 __________ __________
8 GENERAL FUND TOTAL $0 $7,176
95
10 HIGHWAY FUND 2025-26 2026-27
11 All Other $0 $2,496
12 __________ __________
13 HIGHWAY FUND TOTAL $0 $2,496
1140 '
15 Amend the bill by relettering or renumbering any nonconsecutive Part letter or section
16 number to read consecutively.
17 SUMMARY
1188 This amendment replaces the bill and changes the title. With respect to coverage of a
1199 prescription drug on a carrier's formulary for the treatment of metastatic cancer and
2200 associated conditions, the amendment prohibits a health insurance carrier or utilization
2211 review organization from requiring an enrollee to use a step therapy protocol before the
2222 carrier provides coverage of a prescription drug approved by the United States Food and
2233 Drug Administration. The amendment also adds an appropriations and allocations section.
2244 FISCAL NOTE REQUIRED
2255 (See attached)
Page 2 - 132LR0578(02)
COMMITTEE AMENDMENT

[DELETED: LD:(RC A “ t H 1 L 1 “ A R0C1A2'3A4f5' 6A7m c o i t a t i t j o t h c8p9 0C1s2 38  S t f m c a a c p4N5o6c7p8S9  T f a a 4  A a a0a1A2D]
[DELETED: IcDoD262r$0$___L$0$D262r$0$___L$0$05A6n8T9p d o a c f f t t o m c a0a1r2c3D4F5(]